Tender detail

Non-exclusive rebate agreement for pegfilgrastim medicines for 2027

Summary

DAK-Gesundheit and the ARGE-OH-BioTech Pegfilgrastim health insurers are seeking non-exclusive rebate agreements for medicines containing pegfilgrastim (ATC L03AA13). The agreements are intended to run from 1 January to 31 December 2027, with an option to extend for 12 months, and will end earlier if an exclusive agreement takes effect.

Reference number
fdac0e1d-a511-4d41-96d0-abdac85b8a22
Buyer
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2028-11-19
Status
Open
Contract subject
Supplies
Estimated value
1,00 EUR
Source
DEU_BKMS

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.